Brief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
21/08/2026 14:45
BRIEF-Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility Aug 21 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS:
US FDA COMPLETES UNANNOUNCED INSPECTION OF CAPLIN STERILES GUMMIDIPOONDI FACILITY
US FDA OBSERVATIONS PROCEDURAL IN NATURE, DOES NOT PERTAIN TO DATA INTEGRITY
FACILITY RECEIVES FORM 483 WITH 10 PROCEDURAL OBSERVATIONS
Source text: ID:nBSEbJZf2W
Further company coverage: CAPL.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees